Fig. 2From: Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisEstimated treatment effects for the 4 outcomes, 3 matching and 2 weighting strategies and 2 causal effects, with and without pairwise censoring in matched cohortsBack to article page